Found: 4
Select item for more details and to access through your institution.
Bismuth-Containing Quadruple Therapy for Helicobacter pylori Eradication: A Randomized Clinical Trial of 10 and 14 Days.
- Published in:
- Digestive Diseases & Sciences, 2024, v. 69, n. 7, p. 2540, doi. 10.1007/s10620-024-08460-3
- By:
- Publication type:
- Article
Efficacy and safety of a 14‐day modified concomitant therapy for refractory Helicobacter pylori infection: a pilot study.
- Published in:
- Journal of Gastroenterology & Hepatology, 2023, v. 38, n. 12, p. 2097, doi. 10.1111/jgh.16348
- By:
- Publication type:
- Article
A Report of Two Cases of Meningoencephalitis Caused by Streptococcus intermedius.
- Published in:
- 2024
- By:
- Publication type:
- Case Study
Tetracycline Three Times Daily Versus Four Times Daily in Bismuth‐Containing Quadruple Therapy as the First‐Line Treatment of Helicobacter pylori Infection: A Multicenter, Noninferiority, Randomized Controlled Trial.
- Published in:
- Helicobacter, 2024, v. 29, n. 4, p. 1, doi. 10.1111/hel.13121
- By:
- Publication type:
- Article